Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Andreone

Showing results (101-110 of 204) with videos related to

Pageof 21
Sort By:
Journal of Hepatology|June 29, 2016
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antiviralsFabio Conti, Federica Buonfiglioli, Alessandra Scuteri, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 8, 2008
Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infectionFlorian Bihl, Elisabetta Loggi, John V Chisholm, et al.
European Radiology|September 13, 2017
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosisMatteo Renzulli, Federica Buonfiglioli, Fabio Conti, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 28, 2017
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practiceElisabetta Loggi, Stefano Gitto, Silvia Galli, et al.
Annals of Hepatology|January 10, 2018
Worsening of Serum Lipid Profile after Direct Acting Antiviral TreatmentStefano Gitto, Arrigo F G Cicero, Elisabetta Loggi, et al.
Transplantation|November 20, 2002
Efficacy of lamivudine therapy for advanced liver disease in patients with precore mutant hepatitis B virus infection awaiting liver transplantationPietro Andreone, Maurizio Biselli, Annagiulia Gramenzi, et al.
Journal of Hepatology|October 11, 2012
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis BLorenzo Micco, Dimitra Peppa, Elisabetta Loggi, et al.
Viruses|June 2, 2021
Hepatitis B Virus-Related Cryoglobulinemic Vasculitis: Review of the Literature and Long-Term Follow-Up Analysis of 18 Patients Treated with Nucleos(t)ide Analogues from the Italian Study Group of Cryoglobulinemia (GISC)Cesare Mazzaro, Luigino Dal Maso, Laura Gragnani, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 20, 2005
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled studyMaurizio Biselli, Pietro Andreone, Annagiulia Gramenzi, et al.
Plos One|November 11, 2017
Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methodsElisabetta Loggi, Silvia Galli, Giovanni Vitale, et al.
Pageof 21

Showing results (101-110 of 204) with videos related to

Sort By:
Pageof 21
Journal of Hepatology|June 29, 2016
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antiviralsFabio Conti, Federica Buonfiglioli, Alessandra Scuteri, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 8, 2008
Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infectionFlorian Bihl, Elisabetta Loggi, John V Chisholm, et al.
European Radiology|September 13, 2017
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosisMatteo Renzulli, Federica Buonfiglioli, Fabio Conti, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 28, 2017
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practiceElisabetta Loggi, Stefano Gitto, Silvia Galli, et al.
Annals of Hepatology|January 10, 2018
Worsening of Serum Lipid Profile after Direct Acting Antiviral TreatmentStefano Gitto, Arrigo F G Cicero, Elisabetta Loggi, et al.
Transplantation|November 20, 2002
Efficacy of lamivudine therapy for advanced liver disease in patients with precore mutant hepatitis B virus infection awaiting liver transplantationPietro Andreone, Maurizio Biselli, Annagiulia Gramenzi, et al.
Journal of Hepatology|October 11, 2012
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis BLorenzo Micco, Dimitra Peppa, Elisabetta Loggi, et al.
Viruses|June 2, 2021
Hepatitis B Virus-Related Cryoglobulinemic Vasculitis: Review of the Literature and Long-Term Follow-Up Analysis of 18 Patients Treated with Nucleos(t)ide Analogues from the Italian Study Group of Cryoglobulinemia (GISC)Cesare Mazzaro, Luigino Dal Maso, Laura Gragnani, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 20, 2005
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled studyMaurizio Biselli, Pietro Andreone, Annagiulia Gramenzi, et al.
Plos One|November 11, 2017
Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methodsElisabetta Loggi, Silvia Galli, Giovanni Vitale, et al.
Pageof 21